{"resourceType": "Bundle", "id": "1", "type": "collection", "entry": [{"resource": {"resourceType": "AllergyIntolerance", "id": "1", "clinicalStatus": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical", "code": "active"}]}, "verificationStatus": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/allergyintolerance-verification", "code": "confirmed"}]}, "type": null, "category": null, "criticality": "low", "code": {"coding": [{"system": "http://snomed.info/sct", "code": "419199007", "display": "Allergy to substance (finding)"}], "text": "Allergy to substance (finding)"}, "patient": {"reference": "Patient/1"}, "recordedDate": "1999-08-17T10:44:47+02:00"}}, {"resource": {"resourceType": "Immunization", "id": "1", "status": "completed", "vaccineCode": {"coding": [{"system": "http://hl7.org/fhir/sid/cvx", "code": "207", "display": "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose"}], "text": "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose"}, "patient": {"reference": "Patient/1"}, "encounter": {"reference": "Encounter/1"}, "occurrenceDateTime": null, "primarySource": true, "occurrenceString": "2021-02-05"}}, {"resource": {"resourceType": "Patient", "id": "1", "name": [{"use": "official", "family": "Treutel", "given": ["Kym", "Jonell"], "prefix": ["Ms."]}], "telecom": [{"system": "phone", "value": "555-353-8795", "use": "home"}], "gender": "female", "birthDate": "1998-04-03", "address": [{"line": ["663 Medhurst Flat Apt 42"], "city": "New Bedford", "state": "Massachusetts", "postalCode": "02747", "country": "US"}], "maritalStatus": null, "multipleBirthBoolean": false, "communication": [{"language": {"coding": [{"system": "urn:ietf:bcp:47", "code": "en-US", "display": "English (United States)"}], "text": "English (United States)"}}]}}, {"resource": {"resourceType": "Encounter", "id": "1", "status": "unknown", "class": {"system": "http://terminology.hl7.org/CodeSystem/v3-ActCode", "code": "AMB"}, "type": null, "subject": {"reference": "Patient/1", "display": "Ms. Kym Jonell Treutel"}, "participant": null, "period": null, "serviceProvider": null}}]}
This clinical note regards a patient named Ms. Kym Jonell Treutel. The patient's primary contact number is 555-353-8795 and she uses this number at her home. She resides at the address 663 Medhurst Flat Apt 42, New Bedford, Massachusetts, 02747 in the United States. Ms. Treutel, born on April 3rd, 1998, communicates in English (United States). She is not a twin or a multiple birth.

In Ms. Treutel's clinical history, there lies an active, confirmed allergy, though it is of low criticality. The allergy is related to a substance, but the specific substance is not detailed. This finding was initially recorded on August 17, 1999, at precisely 10:44:47 AM with the timezone information of +02:00.

Furthermore, Ms. Treutel has received a SARS-COV-2 (COVID-19) immunization. The vaccine administered was the mRNA, spike protein, LNP, preservative-free, 100 mcg/0.5mL dose variant. The immunization, which is confirmed to have been sourced from a reliable primary source, was completed on February 5, 2021.

There is an encounter referenced in her record, but the status of this encounter is unknown. The classification code labels it as an ambulatory encounter, but further specifics are not provided.
This clinical note regards a patient named XXXXXXX. XXXXXXX. The patient's primary contact number is XXXXXXX and XXXXXXX uses this number at XXXXXXX home. XXXXXXX resides at the address 663 XXXXXXX, XXXXXXX, XXXXXXX, 02747 in the United States. XXXXXXX. XXXXXXX, born on XXXXX, communicates in English (United States). XXXXXXX is not a twin or a multiple birth.

In XXXXXXX. XXXXXXX's clinical history, there lies an active, confirmed allergy, though it is of low criticality. The allergy is related to a substance, but the specific substance is not detailed. This finding was initially recorded on XXXXX, at precisely XXXXX with the timezone information of +XXXXX.

Furthermore, XXXXXXX. XXXXXXX has received a SARS-COV-2 (COVID-19) immunization. The vaccine administered was the mRNA, spike protein, LNP, preservative-free, 100 mcg/0.5mL dose variant. The immunization, which is confirmed to have been sourced from a reliable primary source, was completed on XXXXX.

There is an encounter referenced in XXXXXXX record, but the status of this encounter is unknown. The classification code labels it as an ambulatory encounter, but further specifics are not provided.